EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisited

Filippo Vernia iD, Angelo Viscido, Giovanni Latella

Journal of Clinical Apheresis · 2023

DOI: 10.1002/jca.22091 ↗

At a glance

Übersichtsarbeit in Journal of Clinical Apheresis, 2023. Written by Filippo Vernia and 2 co-authors. Institution: Gastroenterology Unit, Division of Gastroenterology, Hepatology, and Nutrition, Department of Life, Health and Environmental Sciences, University of …. Major MEDLINE topics: Colitis, Ulcerative, Biosimilar Pharmaceuticals. Cited 2 times so far (Crossref); 77 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Adsorptive cytapheresis proves effective in a proportion of patients affected by ulcerative colitis. Relatively high cost and the need for apheresis facilities, prevented the widespread use of this therapeutic approach. More so following the introduction of anti‐TNFα biosimilars which proved both effective and inexpensive. Anti‐TNFα agents, however, are burdened by high rate of primary and secondary non‐response and prompt switching to new, high‐cost biologics, and small molecules. The present review analyzes advantages and disadvantages of adsorptive cytapheresis in the present clinical scenario and suggests its repositioning in the therapeutic workup of selected subgroups of ulcerative colitis patients. The extremely favorable safety profile makes adsorptive cytapheresis a viable therapeutic option in elderly and high‐risk UC patients, as well as potential second‐line treatment in corticosteroid‐dependent patients and poor responders to first‐line biologics.

Subjects

MeSH terms (MEDLINE)

Colitis, UlcerativeBiosimilar PharmaceuticalsHumansAgedCytapheresisAdrenal Cortex HormonesRemission InductionTumor Necrosis Factor-alphaTreatment OutcomeGranulocytesMonocytes

Author keywords

adsorptive cytapheresisefficacyinflammatory bowel diseasesmechanisms of actionsafetyside effectsulcerative colitis

Substances

Biosimilar PharmaceuticalsAdrenal Cortex HormonesTumor Necrosis Factor-alpha

Authors and institutions

  • Gastroenterology Unit, Division of Gastroenterology, Hepatology, and Nutrition, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

ORCID profiles: Filippo Vernia

Cite

APA

Vernia, F., Viscido, A., & Latella, G. (2023). Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisited. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.22091

Vancouver

Vernia F, Viscido A, Latella G. Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisited. Journal of Clinical Apheresis. 2023. doi:10.1002/jca.22091

BibTeX
@article{Vernia2023,
  author = {Vernia, Filippo and Viscido, Angelo and Latella, Giovanni},
  title = {Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisited},
  journal = {Journal of Clinical Apheresis},
  year = {2023},
  doi = {10.1002/jca.22091}
}
Start for free →